PUBLIC CONSULTATION NOW OPEN ** Draft International Consensus Guideline on Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) **

The ADDIKD draft guideline is open for public consultation until midnight (AEST) 31st May 2022.  The BOPA Committee would appreciate your input with this process.

The Draft Guideline can be accessed here: https://www.eviq.org.au/getmedia/7f42c39e-2100-40aa-b358-575c485ce3da/Draft-ADDIKD-Guideline-V7.aspx

If you have any questions, please contact Geeta Sandhu on [email protected] submit you feedback please scan the QR code below or see the consultation information here: https://www.bopa.org.uk/resources/addikd-flyer-final/

Latest News

By Joseph Williams on 20th December 2024

Update from the UK Pharmacy Professional Leadership Advisory Board – December 2024

Update from the UK Pharmacy Professional Leadership Advisory Board The UK Pharmacy Professional Leadership Advisory Board met for the fourth time on 10 December 2024. Through the Board’s work, closer…

Read article
By BOPA Committee on 20th December 2024

BOPA Podcast – Let’s Talk About Elastomeric Pumps

The next episode of Let’s Talk About SACT is Let’s talk about Elastomeric Pumps. In this episode we are joined by Chiara Creed, Shumi Tattersfield and Jane Neerkin. We discuss…

Read article
By BOPA Research Committee on 18th December 2024

The BOPA-PRUK research award – launch now open for submissions

The BOPA-PRUK research award This award provides pharmacy professionals who are new to research with the extra incentive to get their research career started. Pharmacy Research UK (PRUK) and the…

Read article
By BOPA Committee on 18th December 2024

Nordic Social Pharmacy Conference Glasgow June 2025

We are thrilled to invite you to the NORDIC Social Pharmacy Conference 2025, 4th – 6th June 2025 at the prestigious University of Strathclyde Technology and Innovation Centre in Glasgow, UK.…

Read article